Dr Andrei Gudkov, PhD, DSci, is a preeminent cancer researcher who serves as Senior Vice President, Research Technology and Innovation, Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant at Roswell Park Comprehensive Cancer Center ([ Ссылка ]).
Dr. Gudkov is responsible for building on the basic and translational research strengths of the Cell Stress Biology program in DNA damage and repair, photodynamic therapy, thermal and hypoxic stress and immune modulation.
Dr. Gudkov assists the President & CEO in developing and implementing strategic plans for new scientific programs and enhancing collaborations in research programs with regional and national academic centers as well as with industry.
Before joining Roswell Park, Dr. Gudkov served as chair of the Department of Molecular Genetics at Lerner Research Institute, Cleveland Clinic Foundation, and Professor of Biochemistry at Case Western University. He earned his doctoral degree in Experimental Oncology at the Cancer Research Center, USSR and a Doctorate of Science (D.Sci) in Molecular Biology at the Moscow State University, USSR. He has authored or co-authored over 135 scientific articles and holds 27 patents.
Dr. Gudkov is also an accomplished entrepreneur who founded Cleveland BioLabs, Inc., OncoTartis LLC and Everon Biosciences, Inc.
He holds the position of Director & Chief Scientific Advisor at Panacela Labs, Inc., Chief Scientific Officer of OncoTartis LLC, Chief Scientific Officer for Everon Biosciences, Inc., Chief Science Officer at Genome Protection, Inc. and Chief Scientific Officer of Cleveland BioLabs, Inc. Andrei V. Gudkov is also on the board of Incuron LLC.
Dr. Gudkov also serves on the Scientific Advisory Board and is author of the founding concept for the Vaika ([ Ссылка ]) program, a not-for-profit charitable medical research organization with a mission to extend the health-span and life-span of domestic animals, with a focus on aged sled dogs.
